4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-039501
Chief Commercial Officer sold 2,050 shares at $97.58 ($200,039)
- Chief Commercial Officer acquired 2,050 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hoerter Steven L. Chief Commercial Officer | 2018-06-22 | Option exercise | +2,050 | $39.76 | $81,508 | 2,050 | D |
| Hoerter Steven L. Chief Commercial Officer | 2018-06-22 | Sale | −2,050 | $97.58 | $200,039 | 0 | D |
| Derivatives | |||||||
| Hoerter Steven L. Chief Commercial Officer | 2018-06-22 | Option exercise · Stock option (right to buy) | −2,050 | 64,750 | D | ||
| Open-market sales · 2,050 sh · avg $97.58 · $200,039 | |||||||
Loading xslF345X03/doc4.xml…